Nuvation Bio Inc. (NUVB) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Gary Hattersley

Chief Scientific Officer

—

$3.38M (3) scheduled

−$3.38M

0

0.0000%

$0.00

—

Dongfang Liu

Chief Medical Officer

—

$1.87M (7) scheduled

−$1.87M

18,000

0.0051%

$127.66K

0.0%

Kerry Wentworth

Chief Regulatory Officer

—

$1.47M (3) scheduled

−$1.47M

53,000

0.0151%

$375.90K

+1,667%

David C. Hanley

Chief Technical Operations

—

$1.43M (1) scheduled

−$1.43M

24,000

0.0068%

$170.22K

0.0%

Stacy Markel

Chief People Officer

—

$753.19K (1) scheduled

−$753.19K

32,591

0.0093%

$231.15K

+44.3%

Philippe Sauvage

Chief Financial Officer

—

$286.37K (1) scheduled

−$286.37K

54,131

0.0154%

$383.92K

+692.4%

Robert Mashal

Director

$118.25K (1)

—

+$118.25K

225,000

0.0641%

$1.60M

+125.0%

David Hung

President and CEO

—

59,281,054

16.88%

$420.44M

+1.7%

Junyuan Jerry Wang

CEO, Anheart Therapeutics Ltd.

—

3,866,228

1.10%

$27.42M

−1.4%

Colleen Sjogren

Chief Commercial Officer

—

81,000

0.0231%

$574.48K

+161.3%

Moses Makunje

See Remarks

—

68,137

0.0194%

$483.25K

+292.1%

Nuvation Bio Inc.

What the insiders did Mostly scheduled

By person